Neuropace Inc reports results for the quarter ended in March - Earnings Summary

NeuroPace

05/05/2023 19:29

* Neuropace Inc  NPCE.OQ  reported a quarterly adjusted loss
of 41
cents​​ per share for the quarter ended in March. The mean
expectation of five analysts for the quarter was for a loss
of 46 cents per share.
    * Revenue rose 27.2% to $14.47 million from a year ago;
analysts
expected $12.17 million. 
    * Neuropace Inc's reported EPS for the quarter was a loss
of 41
cents​.
    * The mean earnings estimate of analysts had risen by
about 7.9%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * Neuropace Inc shares had risen by 7.5% this quarter and
gained 234.9% so far this year.
    * The company reported a quarterly loss of $10.38 million.
    * Wall Street's median 12-month price target for Neuropace
Inc is
$6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
5 at 06:29 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.46          -0.41          Beat
 Dec. 31 2022      -0.49          -0.45          Beat
 Sep. 30 2022      -0.53          -0.48          Beat
 Jun. 30 2022      -0.44          -0.52          Missed